CVR Medical Corp
CVR Medical Corp operates in various business sectors.
CVR Medical Corp (B3BN) - Net Assets
Latest net assets as of September 2022: €-4.81 Million EUR
Based on the latest financial reports, CVR Medical Corp (B3BN) has net assets worth €-4.81 Million EUR as of September 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€8.60K) and total liabilities (€4.82 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €-4.81 Million |
| % of Total Assets | -56016.35% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
CVR Medical Corp - Net Assets Trend (2018–2021)
This chart illustrates how CVR Medical Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CVR Medical Corp (2018–2021)
The table below shows the annual net assets of CVR Medical Corp from 2018 to 2021.
| Year | Net Assets | Change |
|---|---|---|
| 2021-12-31 | €-4.46 Million | -65.88% |
| 2020-12-31 | €-2.69 Million | -20.85% |
| 2019-12-31 | €-2.22 Million | -1150.53% |
| 2018-12-31 | €211.58K | -- |
Equity Component Analysis
This analysis shows how different components contribute to CVR Medical Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 712815500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2021)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €28.11 Million | % |
| Total Equity | €-4.46 Million | 100.00% |
CVR Medical Corp Competitors by Market Cap
The table below lists competitors of CVR Medical Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
W.A.G payment solutions plc
LSE:EWG
|
$130.04 |
|
Unicap Modaraba
KAR:UCAPM
|
$130.12 |
|
Innoveren Scientific Inc.
PINK:IVRN
|
$130.13 |
|
EASTFIELD RES
BE:35E
|
$130.33 |
|
Brite-Strike Tactical Illumination Products Inc
PINK:BSTK
|
$129.64 |
|
Worldsec Ltd
LSE:WSL
|
$129.43 |
|
Sante Technology Holdings Inc
PINK:SNTE
|
$129.13 |
|
RSXYZ Public Company Limited
BK:RSXYZ
|
$129.12 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CVR Medical Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2020 to 2021, total equity changed from -2,686,209 to -4,455,786, a change of -1,769,577.
- Net loss of 1,817,620 reduced equity.
- New share issuances of 90,000 increased equity.
- Other factors decreased equity by 41,957.
Equity Change Factors (2020 to 2021)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-1.82 Million | -40.79% |
| Share Issuances | €90.00K | +2.02% |
| Other Changes | €-41.96K | -0.94% |
| Total Change | €- | % |
Book Value vs Market Value Analysis
This analysis compares CVR Medical Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | €0.00 | €0.01 | x |
| 2019-12-31 | €-0.02 | €0.01 | x |
| 2020-12-31 | €-0.03 | €0.01 | x |
| 2021-12-31 | €-0.04 | €0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CVR Medical Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-879.31%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | -3517.25% | 0.00% | 0.00x | 6.53x | €-7.46 Million |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | €-4.91 Million |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | €95.22K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | €-1.37 Million |
Industry Comparison
This section compares CVR Medical Corp's net assets metrics with peer companies in the same industry.
No peer company data available for comparison.